Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Pao-Chu Chen | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Pao-Chu Chen — Hualien Tzu Chi Hospital
Academic Profile
Researcher Pao-Chu Chen
Affiliation Hualien Tzu Chi Hospital
Country Taiwan
Scopus ID 37081956700
Documents 30
Citations 307
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ResearchGate Profile Link

Pao-Chu Chen is affiliated with Hualien Tzu Chi Hospital in Taiwan and has contributed to clinical medicine research through indexed scientific publications and interdisciplinary healthcare studies. The academic profile demonstrates measurable citation impact and participation in scientific communication systems associated with international biomedical research visibility.[1]

Abstract

This article summarizes the academic profile and scientific contributions of Pao-Chu Chen from Hualien Tzu Chi Hospital, Taiwan. The researcher has contributed to clinical medicine through indexed publications, interdisciplinary healthcare research, and scholarly communication activities. Citation indicators and publication metrics demonstrate measurable academic visibility within international biomedical databases. The profile reflects participation in scientific dissemination, healthcare investigation, and research collaboration associated with clinical medicine and public health advancement. Recognition within the Health Scientists Awards framework highlights scholarly engagement, publication quality, and contribution to evidence-based healthcare research within contemporary academic and clinical environments.[1]

Keywords

  • Clinical Medicine
  • Biomedical Research
  • Health Sciences
  • Healthcare Studies
  • Scopus Author Profile
  • Health Scientists Awards

Introduction

Clinical medicine research contributes to evidence-based healthcare practices, disease management, and interdisciplinary scientific advancement. Researchers engaged in this field support medical knowledge dissemination through peer-reviewed publications, healthcare investigations, and collaborative scientific communication systems within international academic and clinical research environments.[2]

Research Profile

Pao-Chu Chen maintains an academic profile associated with Hualien Tzu Chi Hospital and indexed scientific publications in clinical medicine. Bibliometric indicators demonstrate research visibility through citation activity, scholarly dissemination, and participation in international scientific databases supporting healthcare-related academic communication.[1]

Research Contributions

The researcher has contributed to clinical medicine through healthcare investigations, biomedical publication activities, and scientific collaboration. Research dissemination through indexed journals supports the exchange of validated medical knowledge and strengthens interdisciplinary communication within international healthcare and biomedical research communities.[3]

Publications

The publication record associated with Pao-Chu Chen includes indexed scientific articles contributing to clinical medicine and healthcare research. Peer-reviewed publications support citation visibility, academic dissemination, and integration into international bibliographic databases used for scholarly communication and biomedical knowledge distribution.[1]

Research Impact

Research impact is reflected through publication indexing, citation metrics, and participation in scientific communication systems. The researcher’s academic profile demonstrates measurable scholarly visibility and contribution to healthcare-related scientific literature within internationally recognized biomedical and clinical research databases.[1]

Award Suitability

The academic profile of Pao-Chu Chen aligns with recognition criteria associated with scientific publication activity, citation visibility, and healthcare research contribution. Participation in indexed scholarly communication systems demonstrates engagement with biomedical dissemination practices supporting international academic and clinical research advancement.[4]

Conclusion

Pao-Chu Chen demonstrates sustained involvement in clinical medicine research through indexed publications, citation visibility, and scientific dissemination activities. The academic profile reflects interdisciplinary healthcare engagement and contribution to biomedical scholarship within international research environments supporting evidence-based healthcare communication and scientific advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Pao-Chu Chen, Author ID 37081956700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=37081956700
  2. Subramani, K., Su, C.-C., Wang, J.-H., Huang, H.-S., Hsu, C.-S., Chen, P.-C., & Chu, T.-Y. (2025). Tubal ligation exacerbates ovulation-driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin. The Journal of Pathology.
    https://pathsocjournals.onlinelibrary.wiley.com/doi/abs/10.1002/path.70064
  3. Chu, T., Chen, Pao-Chu, Khine, A. A., et al. (2025). Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma. Neoplasia.
    https://pubmed.ncbi.nlm.nih.gov/41046768/
  4. Health Scientists Awards. (n.d.). Academic recognition and scientific excellence framework.
    Health Scientists Awards

Eleftherios Papaeleftheriou | Clinical Medicine | Top Clinical Research Award

Published on by Health Scientists

Top Clinical Research Award

Eleftherios Papaeleftheriou
St. Mary’s Hospital Mülheim an der Ruhr, Germany

Eleftherios Papaeleftheriou
Researcher Eleftherios Papaeleftheriou
Affiliation St. Mary’s Hospital Mülheim an der Ruhr
Country Germany
Scopus ID 53881624200
Documents 2
Citations 7
h-index 1
Subject Area Clinical Medicine
Event Health Scientists Awards
Scopus Profile View Profile

The Top Clinical Research Award recognizes the scholarly and clinical research contributions of Eleftherios Papaeleftheriou associated with St. Mary’s Hospital Mülheim an der Ruhr in Germany. The recognition reflects engagement in Clinical Medicine research, scientific communication, and internationally indexed academic dissemination through peer-reviewed publication activity.[1] The award framework acknowledges measurable scholarly participation within clinical and healthcare-oriented research environments supported by internationally recognized academic indexing systems.[2] Additional scholarly infrastructure and citation indexing resources further support international accessibility and publication discoverability.[3]

Abstract

Eleftherios Papaeleftheriou is associated with scholarly activities in Clinical Medicine and healthcare-related research dissemination. Indexed academic contributions reflect participation in peer-reviewed publication systems, citation-based evaluation, and scientific communication relevant to clinical and medical investigation.[1] Research visibility supported through international academic platforms contributes to broader engagement within healthcare and clinical research communities.[3]

Keywords

  • Clinical Medicine
  • Medical Research
  • Scientific Dissemination
  • Clinical Investigation
  • Healthcare Innovation
  • Academic Publications
  • Indexed Research

Introduction

Academic recognition programs in healthcare and biomedical sciences acknowledge scholarly contribution and international scientific communication. The Health Scientists Awards Top Clinical Research Award recognizes researchers engaged in clinical investigation and indexed dissemination.[2] Eleftherios Papaeleftheriou demonstrates scholarly involvement in Clinical Medicine through indexed publications and citation-based evaluation, contributing to academic visibility and engagement within broader medical research communities.[1]

Research Profile

Eleftherios Papaeleftheriou is affiliated with St. Mary’s Hospital Mülheim an der Ruhr in Germany and maintains a scholarly profile indexed through Scopus academic databases.[1] The research profile includes two indexed documents, seven citations, and an h-index value of one, demonstrating participation in scholarly communication and clinical research dissemination. The researcher’s academic activities are associated with Clinical Medicine and healthcare-oriented scientific inquiry, supporting knowledge dissemination within peer-reviewed and internationally accessible research environments.[3]

Research Contributions

The scholarly activities associated with Eleftherios Papaeleftheriou contribute to medical and healthcare-oriented academic communication through indexed publication and citation-based dissemination systems.[1]

  • Participation in clinical and healthcare-related academic research.
  • Contribution to peer-reviewed scientific publication systems.
  • Support for internationally indexed research dissemination.
  • Engagement in citation-based scholarly communication activities.

Publications

Indexed publications associated with Eleftherios Papaeleftheriou contribute to academic visibility and accessibility within international scientific databases. Citation metrics and indexed documentation support evaluation of scholarly dissemination and clinical research engagement.[1]

  1. Peer-reviewed publications associated with Clinical Medicine.
  2. Scientific dissemination through internationally indexed academic databases.
  3. Citation-based contribution to healthcare-related scholarly communication.

Research Impact

Research impact within Clinical Medicine is commonly evaluated through publication visibility, citation activity, and participation in internationally recognized scientific dissemination systems. The indexed academic profile associated with Eleftherios Papaeleftheriou reflects measurable scholarly engagement within healthcare-oriented research environments.[1] Recognition through international academic award frameworks may additionally support interdisciplinary networking, collaborative healthcare investigation, and broader scientific communication opportunities.[2]

Award Suitability

The academic and clinical research profile of Eleftherios Papaeleftheriou reflects characteristics associated with scholarly recognition programs, including indexed publication activity, citation-based visibility, and participation in international scientific dissemination systems.[1] The researcher’s engagement within Clinical Medicine contributes to healthcare-related academic communication and supports continued participation within global scientific and medical research initiatives.[3]

Conclusion

Eleftherios Papaeleftheriou demonstrates scholarly participation within Clinical Medicine through indexed publication activity, scientific dissemination, and engagement in internationally accessible healthcare research systems.[1] Citation indicators and publication visibility collectively support recognition within academic and clinical research communities.[3] The Top Clinical Research Award under the Health Scientists Awards framework represents acknowledgment of scholarly contribution, healthcare-oriented scientific engagement, and participation in international research dissemination initiatives.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Eleftherios Papaeleftheriou, Author ID 53881624200. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=53881624200
  2. Health Scientists Awards. (n.d.). International academic recognition and healthcare research award framework.

    https://healthscientists.org/
  3. Sowislok, A., Gruber, G., Kaschani, F., Kaiser, M., Papaeleftheriou, E., & Jäger, M. (2025). Intraoperative Biologization of β-TCP and PCL-TCP by Autologous Proteins. PubMed.

    https://pubmed.ncbi.nlm.nih.gov/41003411/

Nabil Alageli | Clinical Medicine | Research Excellence Award

Published on by Health Scientists

Assoc. Prof. Dr. Nabil Alageli | Clinical Medicine | Research Excellence Award

Consultant Orthopaedic Surgeon | Tripoli University Hospital | Libya

Prof. Nabil A. Alageli is a distinguished consultant orthopaedic and spine surgeon and an associate professor of surgery whose career reflects longstanding commitment to clinical excellence, academic leadership, and national health-system development. His expertise spans complex trauma, spinal injuries, degenerative spine disorders, arthroscopic procedures, and joint reconstruction, complemented by substantial experience in managing large tertiary hospitals and advancing medical training programs.His contributions to hospital governance, health-system reform initiatives, and professional societies underscore his broader societal impact, reflecting a career dedicated not only to surgical practice but also to advancing healthcare quality, institutional capacity, and community service. He has 25 citations from 3 documents with an h-index of 2.

Citation Metrics (Scopus)

25

20

15

10

5

0

Citations
25

Documents
3

h-index
2

                       🟦 Citations             🟥 Documents          🟩 h-index

View Google Scholar Profile
 View Scopus Profile
 View Orcid Profile

Featured Publications

Dieter Melchart | Mental Health | Research Excellence Award

Published on by Health Scientists

Prof. Dr. Dieter Melchart | Mental Health | Research Excellence Award

Professor | Deggendorf Institute of Technology DIT | Germany

Prof. Dr. med. Dieter Melchart is an accomplished health scientist whose work spans naturopathy, complementary medicine, and traditional medical systems. He has held prominent academic positions, including professorial roles in leading European institutions, where he contributed to the development of competence centers dedicated to complementary medicine and naturopathic research. His scholarship focuses on the clinical evaluation of acupuncture, traditional Chinese medicine, lifestyle medicine, and individualized health management, advancing evidence-based integration of traditional practices into modern healthcare. Through his leadership in research, teaching, and clinical innovation, Prof. Melchart has achieved substantial societal impact by promoting holistic, evidence-aligned approaches that enhance patient well-being and strengthen the connection between traditional knowledge and contemporary health science. He has 8443 citations from 179 documents with an h-index of 40.

Citation Metrics (Scopus)

10000

8000

6000

4000

2000

0

 

Citations
8,446

Documents
179

h-index
40
                             🟦 Citations          🟥 Documents      🟩 h-index


View Google Scholar ProfileView Scopus ProfileView Orcid Profile

Featured Publications

Ashiquir Rahaman | Mental Health | Best Researcher Award

Published on by Health Scientists

Mr. MD. Ashiquir Rahaman | Clinical Psychology | Best Researcher Award 

Lecturer | University of Dhaka | Bangladesh

Md. Ashiquir Rahaman is an accomplished academic and clinical psychologist whose professional expertise spans clinical practice, research, and academic instruction, with a strong focus on mental health, neurodevelopmental disorders, and psychosocial well-being. Currently serving as a Lecturer at the Department of Clinical Psychology, University of Dhaka, he has contributed extensively to the advancement of clinical training, supervision, and mental health education. His prior professional experience at the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), reflects a deep engagement with HIV prevention, counselling, and mental health support for marginalized populations, underscoring his commitment to public health and human welfare. Over his academic career, he has co-authored numerous research publications in internationally recognized journals such as Frontiers in Genetics, Journal of Autism and Developmental Disorders, Neuropsychological Rehabilitation, BMC Public Health, International Journal for Equity in Health, and Molecular Genetics and Genomic Medicine, among others. His scholarly works address critical topics including autism spectrum disorder, pain management, well-being assessment, and culturally sensitive psychological interventions. In addition to his research, he has been actively involved in national and international academic collaborations, contributing to policy and program development for mental health and behavioral interventions. His leadership as a clinical supervisor and trainer has played a pivotal role in shaping the next generation of psychologists in Bangladesh. A recipient of the Begum Azizun Nesa Memorial Gold Award for academic excellence, he exemplifies intellectual rigor and compassionate practice. Through his integrated approach combining clinical psychology, community engagement, and evidence-based research, Md. Ashiquir Rahaman continues to contribute meaningfully to global mental health discourse, advancing culturally attuned therapeutic practices and promoting psychological resilience within diverse communities. He has 34 citations from 8 documents with an h-index of 3.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Akter, H., Rahman, M. M., Sarker, S., Basiruzzaman, M., Islam, M. M., … (2023). Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders. Frontiers in Genetics.

2. Rahman, M. M., Uddin, K. M. F., Al Jezawi, N. K., Karuvantevida, N., Akter, H., … (2019). Gonadal mosaicism of large terminal de novo duplication and deletion in siblings with variable intellectual disability phenotypes. Molecular Genetics & Genomic Medicine.

3. Rahaman, M. A., Lopa, M., Uddin, K. M. F., Baqui, M. A., Keya, S. P., Faruk, M. O., … (2021). An exploration of physical and phenotypic characteristics of Bangladeshi children with autism spectrum disorder. Journal of Autism and Developmental Disorders.

4. Iqbal, Y., Jahan, R., Rahaman, M. A., & Faruk, M. O. (2021). Women’s experiences during COVID-19 in Bangladesh. International Perspectives in Psychology.

5. Jahan, R., Rahaman, M. A., & Das, A. (2024). NGOs working on mental health in Bangladesh. In Mental Health in Bangladesh: From Bench to Community.

Md. Ashiquir Rahaman’s work advances the integration of clinical psychology with public health innovation, enhancing mental health care accessibility and culturally sensitive interventions. His research and community initiatives contribute to improving psychological well-being, reducing stigma, and shaping evidence-based mental health policies in low- and middle-income settings.

Siyu Chen | Pharmacology | Best Researcher Award

Published on by Health Scientists

 Prof. Siyu Chen | Pharmacology | Best Researcher Award

Professor | China Pharmaceutical University | China

Dr. Chen Siyu currently serves as the Deputy Director of the Department of Biochemistry at the School of Life Sciences and Technology, China Pharmaceutical University, where he is also a Professor, Doctoral Supervisor, and Chief Young Scientist of the National Key Research and Development Program. He obtained his academic training in biochemistry and molecular biology, cultivating a strong foundation in metabolic and biochemical sciences. Dr. Chen’s research primarily focuses on Target Discovery and Intervention Strategies for Metabolic Diseases, aiming to elucidate molecular mechanisms and identify novel therapeutic targets for metabolic regulation. He has published extensively as first or corresponding author in leading international journals such as Advanced Science, Nature Communications, and Gut Microbes, with his work widely cited by peers. His innovative research has led to the granting of national patents and multiple ongoing patent applications. Dr. Chen has successfully led major research projects under national and provincial funding programs, including the National Key R&D Program for Young Scientists, the National Natural Science Foundation for Young Scientists, and the Jiangsu Province Excellent Youth Fund. Recognized for his scholarly excellence, he received the Outstanding Doctoral Dissertation Award of Jiangsu Province. In addition to his research, Dr. Chen contributes actively to the academic community as a Young Member of the Metabolism Committee of the Chinese Society of Biochemistry, Director of the Jiangsu Society of Developmental Biology, and Editorial Board Member of Journal of China Pharmaceutical University and Progress in Biochemistry and Biophysics. He also serves as a Guest Editor for Frontiers in Endocrinology and a regular reviewer for leading journals including Journal of Hepatology and ACS Nano. He has 1616 citations from 60 documents with an h-index of 24.

Profiles: Scopus | ORCID

Featured Publications

1. Photosensitive biomimetic nanomedicine-mediated recombination of adipose microenvironments for antiobesity therapy. (2025). Advanced Materials.

2. Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity. (2025). Bioengineering and Translational Medicine.

3. Blue light-driven cell cycle arrest in thyroid cancer via Retinal-OPN3 complex. (2024). Cell Communication and Signaling.

4. Luteolin detoxifies DEHP and prevents liver injury by degrading Uroc1 protein in mice. (2024). EMBO Molecular Medicine.

5. Rhodiolin inhibits the PI3K/AKT/mTOR signaling pathway via the glycolytic enzyme GPI in human papillary thyroid cancer. (2024). Phytomedicine.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.